Opendata, web and dolomites

BIOTIMA

Market Opportunity Confirmation for Biomimetic Tissue Matrix Products

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BIOTIMA project word cloud

Explore the words cloud of the BIOTIMA project. It provides you a very rough idea of what is the project "BIOTIMA" about.

morphology    closely    seeded    market    thorough    reduce    employing    analyze    primary    patterned    map    patent    properly    deposited    mimicking    variety    material    efficient    regeneration    substrates    bioplastic    models    hydrogel    versatile    advantages    surface    industry    tissue    biomimetic    feasibility    native    human    toxicity    physiologically    materials    modified    reflect    nano    commercialization    expensive    scientists    plan    drug    vitro    fabrication    functionally    nanoengineering    inhumane    discovery    scaling    confirm    free    elaboration    biosynthetic    functional    biotima    alternatives    tools    biocompatible    environments    lack    standard    solution    piloted    optically    predictive    cell    replication    artificial    pending    tm    clear    techniques    adopter    customers    matrix    composition    business    animal    ferentis    prepare    medicine    roadmap    cosmetics    lab    culture    experiment    clinically    prototypes    effort    stable    organs    made    innovative    preparation    regenerative    cells    tissues    demonstrated    versatility   

Project "BIOTIMA" data sheet

The following table provides information about the project.

Coordinator
FERENTIS 

Organization address
address: SAVANORIU 231
city: VILNIUS
postcode: 2300
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Lithuania [LT]
 Project website http://www.ferentis.eu
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-02-01   to  2015-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FERENTIS LT (VILNIUS) coordinator 50˙000.00

Map

 Project objective

A variety of in vitro human tissue models are used in the fields of testing of cosmetics products, drug discovery and regenerative medicine. Most models made from artificial materials do not properly reflect the native tissue morphology and cell composition, while those made of seeded cells/tissues of specific organs lack versatility and are expensive to use. Ferentis’ Biomimetic Tissue Matrix (BIOTIMA) project addresses the need for efficient toxicity testing/cell culture tools enabling more physiologically relevant, predictive and functional tissue mimicking models, that should become the EU standard in its effort to reduce expensive and inhumane animal testing. Ferentis scientists have developed an innovative patent-pending biosynthetic material –a bioplastic- that is cell-free, stable, biocompatible and optically clear and has demonstrated clinically to promote regeneration of cells. By employing advanced surface nanoengineering techniques, this biosynthetic hydrogel can be deposited, functionally modified and patterned on different substrates, for a variety of lab tissue experiment applications. The unique advantages of our tissue matrix include unique biomimetic properties, most closely mimicking those of the real tissue, and advanced nano-fabrication methods, allowing a cost efficient, versatile and easy to use solution. The prototypes of our TM cell culture tools have been demonstrated in relevant testing environments and now are being piloted with our early adopter customers, with a primary focus on the cosmetics industry. A thorough feasibility study and an elaboration of a business plan is needed in order to analyze the market, map and confirm commercialization alternatives and prepare the roadmap for scaling-up in preparation for Phase II, market replication.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIOTIMA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BIOTIMA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.2.1.2.)

S3D (2015)

Feasibility study to determine the use of ITS technology to replace nuclear density meters in mining, dredging and other areas of hydraulic transport.

Read More  

FREE-D (2015)

CNC dynamic mold for producing freely curved glass panels

Read More  

VENDA NATU-haft (2015)

COHESIVE BANDAGES BASED ON NATURAL FIBRES, WITH ANTIMICROBIAL AND HYDROPHOBIC PROPERTIES BY MLSE TECHNOLOGY

Read More